FormDSignal
35

Trellis Bioscience raises $4.09M in indefinite offering under Reg D 506(b)

Company raise · Open-ended · REDWOOD CITY, CA · Form D filed 2026-10-21

Trellis Bioscience, a Delaware biotech corporation based in Redwood City, CA, is conducting an indefinite offering and has raised $4.09M from 27 investors to date. The offering commenced in October 2024 and remains open.

operating_company

Why now — by persona

  • Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock

People on the filing

Nora MendeChief Financial Officer
Larry KauvarChief Science Officer

Signed by Nora Mende, Chief Financial Officer.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer